Original Research
Accepted on 24 Dec 2025
Beyond Glycemic Control: The Cardiac and Hepatic Benefits of SGLT2 and DPP-4 Inhibitors in Mitigating Chronic Cadmium-Induced Inflammation, Oxidative/Nitrative Stress, Apoptosis and Fibrosis
in Integrative Physiology